Ziphius Vaccines
PrivateCompany Overview
Ziphius Vaccines is a biopharmaceutical company that develops a self-amplifying RNA (saRNA) platform for vaccines and therapeutics to prevent infectious diseases and for protein enhancement therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
self-amplifying RNAsaRNAlipid nanoparticleLNPRNA platformLNP deliveryvaccine developmentRNA vaccinesRNA therapeuticspreclinical biotechrare disease therapyinfectious disease vaccinesgene therapyoncology therapeuticsbiotech licensingdrug delivery systempandemic preparedness
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ziphius Vaccines Comparables
Compare Ziphius Vaccines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immorna | 88% | |
| Replicate Bioscience | 85% | |
| Chimeron Bio | 83% | |
Ziphius Vaccines Funding Rounds
Historical fundraising activity
Ziphius Vaccines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ziphius Vaccines's valuation, stock price, and market status.
See something wrong or outdated?